AIM: To research the etiology, portal vein thrombosis and other features of Budd-Chiari
syndrome (BCS) patients prospectively. METHODS: A total of 75 patients (40 female, 35 …

Background: Primary BCS is a rare form of vascular disease, secondary to underlying
thrombophilia. Because of its rarity and heterogeneous nature, there is a scarcity of …

Objectives: Therapeutic options in Budd-Chiari syndrome (BCS) are highly dependent on
the site and extent of hepatic vein thrombosis. The aim of this study was to evaluate the …

AIM: To evaluate patterns of obstruction, etiological spectrum and non-surgical treatment in
patients with Budd-Chiari syndrome in India. METHODS: Forty-nine consecutive cases of …

BACKGROUND & AIMS: Anticoagulation therapy is recommended for patients with Budd–
Chiari syndrome (BCS). This study aimed to assess the incidence, severity, and risk factors …

Budd-Chiari syndrome (BCS) is a rare disease with an incidence of 0.1 to 10 per million
inhabitants a year caused by impaired venous outflow from the liver mostly at the level of …

Budd-Chiari syndrome is a congestive hepatopathy caused by blockage of hepatic veins.
This syndrome occurs in 1/100 000 in the general population. Hypercoagulable state could …

OBJECTIVES Combined Budd-Chiari syndrome and Portal Vein Thrombosis (BCS-PVT) is a
challenging clinical condition with as yet unknown outcome. The aim of the present study …

Background: Hepatic venous outflow obstruction (Budd–Chiari syndrome) is frequently
encountered as a cause of portal hypertension at our centre. Methods and Results: We …

Budd-Chiari syndrome (BCS) is characterized by the obstruction of hepatic venous outflow
which may occur from the hepatic venules, to the large hepatic veins and the inferior vena …